PCSK9 and coronary artery disorder: Gain-of-function mutations in PCSK9 can cause hypercholesterolemia leading to premature coronary heart disease, whereas loss-of-function mutations are associated with reduced plasma levels of LDL-C and the risk of coronary heart disease [3].